NBRG

Newbridge Acquisition Limited Class A Ordinary Share
NASDAQFINANCIAL SERVICESSHELL COMPANIES

Key Statistics

Market Cap
$75.61M
P/E Ratio
334.00
EPS
$0.03
Beta
52W High
$10.02
52W Low
$9.59
50-Day MA
$9.98
200-Day MA
$9.94
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Newbridge Acquisition Limited Class A Ordinary Share

Newbridge Acquisition Limited Class A Ordinary Shares is an innovative special purpose acquisition company (SPAC) targeting the merger of high-growth, technology-centric enterprises across various sectors. Led by an experienced management team with deep industry expertise, Newbridge leverages advanced market analytics to unearth transformative investment opportunities that foster innovation and operational efficiency. The company's strategic focus is on enhancing shareholder value through meaningful partnerships, positioning it to make a significant impact in the rapidly evolving technological landscape. With a commitment to sustainability and growth, Newbridge seeks to drive long-term success in its targeted industries.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA
Operating Margin0.00%
Return on Equity13.50%
Return on Assets-1.11%
Revenue/Share (TTM)$0.00
Book Value$0.56
Price-to-Book13.99
Price-to-Sales (TTM)
EV/Revenue-
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$6.11M
Float$4.56M
% Insiders9.97%
% Institutions81.63%

Historical Volatility

HV 10-Day
2.46%
HV 20-Day
2.04%
HV 30-Day
1.79%
HV 60-Day
1.77%
HV Rank

Volatility is currently expanding

Latest News

Newbridge Acquisition Limited Announces entering into the Business Combination Agreement with Startech Group Inc.

DELAWARE, U.S, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Newbridge Acquisition Limited (Nasdaq: NBRGU) (the “Company”) today announced the execution of the business combination agreement (the “Business Combination Agreement”) with Startech Group Inc., an emerging life sciences technology company focused on developing products such as functional water and AI-powered healthcare technologies to enhance human longevity (“Startech”).

GlobeNewsWire8/3/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on NBRG and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 8/18/2026